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ABSTRACT Several clones hybridizing with a bovine
ADP/ATP translocase cDNA were isolated from an adult
human liver cDNA library in the vector pEX1. DNA sequence
analysis revealed that these clones encode two distinct forms of
translocase. In particular, two clones specifying the COOH-
end-proximal five-sixths of the protein exhibit a 9% amino
acid sequence divergence and totally dissimilar 3' untranslated
regions. One of these cDNAs is nearly identical in sequence to
an ADP/ATP translocase clone (hp2F1) recently isolated from
a human fibroblast cDNA library [Battini, R., Ferrari, S.,
Kaczmarek, L., Calabretta, B., Chen, S. & Baserga, R.
(1987) J. Biol. Chem. 262, 4355-4359], with three amino acid
changes and a few differences in the 3' untranslated region.
Another clone isolated from the pEX1 library contains a
reading frame encoding the remaining, NH2-end-proximal, 37
amino acids of the translocase. This sequence differs signifi-
cantly (14% amino acid sequence divergence) from the corre-
sponding segment of hp2F1, and the 5' untranslated regions of
the two clones are totally dissimilar. RNA transfer hybridiza-
tion experiments utilizing the clones isolated from the pEX1
library revealed the presence in HeLa cells of three distinct
mRNA species. The pattern of hybridization and the sizes of
these mRNAs suggest a greater complexity of organization and
expression of the ADP/ATP translocase genes in human cells
than indicated by the analysis of the cDNA clones.
The ADP/ATP translocase is an integral protein of the inner
mitochondrial membrane that carries out the exchange be-
tween the extramitochondrial and intramitochondrial ADP
and ATP, linking the processes ofATP production to those of
ATP utilization (1). This protein can thus exert a control on
the rate of oxidative phosphorylation, as well as on the rates
of the energy-consuming processes. Because of its central
role in cellular energy metabolism, the ADP/ATP translocase
is likely to be a highly regulated protein to fit the varying
demands of the cell in relationship to functional, developmen-
tal, and tissue-specific factors. Indeed, evidence coming from
an analysis of the immunological reactivity of the translocator
protein extracted from different tissues (2, 3) and of the tissue
specificity of anti-translocase autoantibodies found in some
heart (4) and liver diseases (5) has strongly suggested the
existence of multiple isoforms of this protein. These findings
fit in well with the emerging concept of a developmental and
tissue-specific control of the apparatus of oxidative phospho-
rylation. The isolation from a human fibroblast cDNA library
of a clone for an ADP/ATP translocase that is growth-
regulated has recently been reported (6).
In this paper, we report on the isolation and structural
characterization of cDNAs for the ADP/ATP translocase
from an adult human liver cDNA library. Evidence is
presented that two different genes for this protein, one of
which may correspond to the gene identified in human
fibroblasts (6), are expressed at the mRNA level in the adult
human liver.t
MATERIALS AND METHODS
Isolation of ADP/ATP Translocase cDNA Clones. A library
that had been constructed by subcloning Pst I fragments
400-1600 base pairs (bp) long from an adult human liver
cDNA library (7) in the plasmid vector pEX1 (8) was screened
by colony hybridization (9), using a nick-translated 1.2-
kilobase (kb) cDNA (T10.1BE9) of the bovine ADP/ATP
translocase (gift of J. Walker, Medical Research Council
Laboratory of Molecular Biology, Cambridge, U.K.) as a
probe. For this purpose, replicate filters were washed at 680C
for 1 hr in 0.1 x SSC ( x SSC is 150 mM NaCl/15 mM
sodium citrate)/0.5% NaDodSO4 and then incubated in 40%
(vol/vol) formamide in 5 x SSC/0.2% NaDodSO4/20 mM
sodium pyrophosphate/1 x Denhardt's solution (1 x Den-
hardt's solution is 0.02% Ficoll/0.02% polyvinylpyrrolidone/
0.02% bovine serum albumin) containing 0.1 mg of sonicated
denatured salmon sperm DNA per ml, at 37°C for 2 hr (10).
Hybridization was then carried out at 37°C for 15 hr in the
same solution containing 2 x 105 cpm of 32P-labeled probe
per ml. The filters were washed at 37°C twice in 40% (vol/vol)
formamide in 5 x SSC/0.2% NaDodSO4 for 30 min, twice in
2 x SSC/0.2% NaDodSO4 for 30 min, and twice in 1 x
SSC/0.2% NaDodSO4 for 30 min. Positive clones were re-
screened and then subcultured in large scale for characteriza-
tion by restriction mapping, using standard procedures (10).
DNA Sequencing. The nucleotide sequence of the isolated
clones was determined by using both the Maxam-Gilbert
method (11) and the dideoxynucleotide chain-termination
method (12). In the latter case, standard techniques were
used for cloning in M13 mpl8 and M13 mpl9 phages (13).
Avian myeloblastosis virus reverse transcriptase (14), 2'-
deoxyadenosine 5'-[a-[35S]thio]triphosphate (15), and 7-
deaza-2'-deoxy-GTP (instead of 2'-deoxy-GTP) (16) were
used in the dideoxy sequencing reactions.
RNA Transfer Hybridization Analysis. Cytoplasmic poly-
somal RNA was extracted from exponentially growing HeLa
cells (maintained in suspension in Eagle's phosphate me-
dium) as previously described (17, 18). Polyadenylylated
RNA was isolated by double passage over an oligo(dT)-
cellulose column (19). Samples of denatured RNA (3 ,g per
lane) were electrophoresed in a 1.1% agarose/5 mM
CH3HgOH gel in 50 mM sodium borate, pH 8.2/0.1 mM
EDTA (19) and transferred to Zeta-Probe membranes (Bio-
Abbreviation: nt, nucleotide(s).
*Present address: Sloan-Kettering Cancer Center, 1275 York Ave-
nue, New York, NY 10021.
tThese sequences are being deposited in the EMBL/GenBank data
base (Bolt, Beranek, and Newman Laboratories, Cambridge, MA,
and Eur. Mol. Biol. Lab., Heidelberg) (accession nos. J03591 for
clone pHAT3, J03592 for clone pHAT8, and J03593 for clone
pHAT14).
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Rad) by electroblotting. The filters were washed, pretreated,
and then incubated for hybridization as described above,
except for the addition of 10% dextran sulfate to the prehy-
bridization and hybridization mixtures. Hybridization was
carried out at 370C for 15 hr with various formamide con-
centrations, as indicated below, depending on the probe
used. 32P-labeled probes were prepared by random-primed
labeling of isolated inserts (20) to a specific activity of 2 x
108 cpm/fug. Filters were washed at 370C, as detailed above.
RESULTS
Isolation and Characterization of Human ADP/ATP Trans-
locase cDNA Clones. Out of 150,000 colonies screened of the
human cDNA library, using a cDNA for the bovine
ADP/ATP translocase as a probe, 26 positively hybridizing
clones were isolated. As judged by insert size and restriction
map analyses, these represented seven different clones, two
nonoverlapping (pHAT3 and pHAT14) and five overlapping
(pHAT5, pHAT8, pHAT22, pHAT27, and pHAT32) (Fig. 1).
The nucleotide sequence of the inserts ofpHAT14 and of the
five overlapping clones was determined by using both the
Maxam-Gilbert method (11) and the dideoxynucleotide
chain-termination method (12), that of the insert of pHAT3,
by the latter method, as described in the legend of Fig. 1.
The nucleotide sequence of the insert ofpHAT14 (190 bp)
revealed a 3'-truncated reading frame of 111 nucleotides (nt),
and, upstream of this, an untranslated region of 79 nt (Fig.
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FIG. 1. Partial restriction map and sequencing strategy of the
inserts of the ADP/ATP translocase cDNA clones. The inserts have
been aligned on the basis of the sequence comparison with the human
translocase clone hp2F1 (6). The scale above the cDNA inserts
indicates the nucleotide position (in kb) relative to the 5' end of the
pHAT14 cDNA insert. For pHAT14, pHAT8, and pHAT3, the black
bar represents the protein-encoding region, the open bar, a 5' or 3'
untranslated region' and the lines, portions of the clones pertaining to
the poly(A), poly(dG), and poly(dC) tails and to vector sequences.
For the clones that overlap pHAT8, the thick line represents the
protein-encoding and the untranslated regions of the cDNA, the thin
line, the tails and vector sequences. The arrows represent the
direction and extent of sequencing from the indicated site. o, Starting
sites (5' end) for sequencing by the Maxam-Gilbert method (11); and
*, by the dideoxynucleotide chain termination method (12). B,
BamHI; P, Pst I; X, Xba I; Bg, Bgl II; SI, Sal I; Sc, Sac I; H, HindIll.
2). The occurrence of a Pst I site at the 3' end of the reading
frame indicated that this insert derived from Pst I cleavage of
a longer insert during subcloning of the library (see Materials
and Methods). A comparison with the derived amino acid
sequence of the cDNA clone for the ADP/ATP translocase
from human fibroblasts (6) showed that the reading frame of
pHAT14 encodes the NH2-end-proximal 37 amino acids of a
related protein.
pHAT8, with an insert size of 1235 bp [including the
poly(A) tail], was the longest clone isolated (Fig. 1). The
inserts of clones pHAT5, -22, and -32 were found to corre-
spond to the regions from nt 440 to nt 1025, from nt 592 to nt
1285, and from nt 403 to nt 1125 of the insert of pHAT8,
respectively (in the numbering system of Fig. 2); pHAT27
had an insert that appeared to be identical to that of
pHAT22, but in the inverted orientation. The cDNA of
pHAT8 contained a 5'-truncated reading frame of 789 nt and
a 3' untranslated region of 326 nt (Fig. 2). Here too, the
occurrence of a Pst I sequence at the 5' end of the reading
frame pointed to the derivation of the insert of pHAT8 -from
Pst I cleavage of a longer insert during the subcloning of the
library. A comparison with the sequence of the ADP/ATP
translocase from human fibroblasts (6) showed that the
reading frame ofpHAT8 encodes a major portion of a related
protein immediately downstream of the segment encoded in
pHAT14. The 3' untranslated region of pHAT8 did not
exhibit a typical polyadenylylation signal (21).
The insert of clone pHAT3 was 1018 bp long, excluding
the poly(A) tail, and contained a 5'-truncated reading frame
of 761 nt and a 3' untranslated region of 257 nt (Fig. 2). Here
again, the occurrence of a Pst I sequence at the 5' end of the
reading frame indicated that the insert of clone pHAT3
derived from Pst I cleavage of a longer insert. The deduced
amino acid sequence showed that this cDNA clone also
codes for a major portion of a protein related to the
ADP/ATP translocase from human fibroblasts (6), from
amino acid 47 to the COOH end. The 3' untranslated region
of pHAT3 exhibited a typical polyadenylylation signal (21)
13 nt upstream of the poly(A) tail (Fig. 2).
Comparison of the ADP/ATP Translocase Clones with
hp2Fl. The protein segments encoded in the pHAT14 and
pHAT8 cDNAs are clearly distinct from the protein encoded
in hp2F1, the clone for ADP/ATP translocase isolated from
a human fibroblast cDNA library (6) (Figs. 2 and 3). In
particular, the reading frame of pHAT14 shows a 79%
nucleotide sequence and an 86% amino acid sequence simi-
larity to the corresponding portion of the reading frame of
hp2F1. The great majority (65%) of the nucleotide changes
are silent. Furthermore, the 5' untranslated region of
pHAT14 is totally dissimilar from the 5' untranslated region
of hp2F1. The reading frame of pHAT8 shows a 78%
nucleotide sequence and a 91% amino acid sequence simi-
larity to the corresponding region of the hp2F1 reading
frame. Here too, the majority (82%) of the nucleotide
substitutions are silent. The 3' untranslated region ofpHAT8
is also very different in sequence from that of pH2F1.
The insert of pHAT3 corresponds to the segment of the
hp2F1 cDNA from nt 137 to the 3' end, including a portion of
the poly(A) tail (Fig. 2). In contrast to the inserts ofpHAT14
and pHAT8, the sequence of the insert of pHAT3 is almost
identical to that of the hp2F1 cDNA. In particular, in the
reading frame, four nucleotide differences were found be-
tween hp2F1 and pHAT3. These discrepancies are located at
nt 197, 332, 485, and 699 (in the numbering system of Fig. 2).
At nt 197 in pHAT3 there is a G, while in hp2F1 an A is
observed. This change also results in an amino acid change,
from Glu in hp2Fl to Gly in pHAT3. It is noted that, in the
translocases from maize (22), Neurospora (23), yeast (24),
and bovine heart (25), a Gly residue is conserved at this
position. At nt 332 and 485, the base substitutions result in
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pHAT14 ACTGCGCGGCGGTGCAAGGCCGGGCTTGGGCGAGAGCACGAACGGGCTGCCTGCGGGCTGAGAGCGTCGAGCTGTCACC
hp2F1 CCGCAGCGCCGTAGTCAAACCGAACCCGGCCCAGTCCCGTCCTGCAGCAGTCTGCCTCCTTCTTTCAAC
120
pHAT14 ~ GTGATCACGCTTGGAGCTTCCTAAAGGACTTCCTGGCCGGGGGCGTCGCCGCTGCCGTCTCCAAGACCGCGGTCGCCCCCATCGAGAGGGTCAAACTGCTGCTGCAG
MetGlyAspHisAlaTrpSerPheLeuLysAspPheLeuAlaGlyGlyValAlaAlawlaValSerLysThrAlaValAlaProIleGluArgValLysLeuLeuLeuGln
pHAT8 ...GTCCAGCAC
* * ValGlnHis
hp2F . . ...... GC . . A.T.TC.... GCC.. . .A. .G. A . A. G. A.G.......C. G....G. T
* Thr * Ala * Leu * * Ala * * * * * * * * * * * Ile * * * * * * * * * * * * * * * * * * *
240
pHAT8 GCCAGCAAGCAGATCGCCGCCGACAAGCAGTACAAGGGCATCGTGGACTGCATTGTCCGCATCCCCAAGGAGCAGGGCGTGCTGTCCTTCTGGAGGGGCAACCTTGCCAACGTCATTCGC
AlaSerLysGlnIleAlaAlaAspLysGlnTyrLysGlyIleValAspCysIleValArgIleProLysGluGlnGlyValLeuSerPheTrpArgGlyAsnLeuAlaAsnVal~leArg
pHAT3 .T. ..T.....A A. A. TA.A... G.G.....T.T..... A.T..C.C.T...G T CA.A
* * * * * * * * Ile * * Val * * * * * * * * * * * * * * * * * * * * * *
hp2FI......... A.T. .A..T.. A. A. TA.A. G.G.. . .T AA. .T. C.C.T.. G...T CA.A
* * * * * Thr * * * * * * * * Ile * * Val * * * * * * * Glu * * * * * * * * * * * * * *
360
pHAT8 TACTTCCCCACTCAAGCCCTCAACTTCGCCTTCAAGGATAAGTACAAGCAGATCTTCCTGGGGGGCGTGGACAGACACGCG---TTCTGGAGGTACTTTGCGGGCAACCTGGCCTCCGGC
TyrPheProThrGlnAlaLeuAsnPheAlaPheLysAspLysTyrLysGlnItePheLeuGlyGlyValAspArgHisAla PheTrpArgTyrPheAlaGlyAanLeuAlaSerGly
pHAT3 . . .G..T..T.A.... C. T.T.. AGAGAA.CCAG ..T... CTC. A. .G. .T. ..A.G. .T
* * * * * * * * * * * * * * * * * * * * * * * * LysArgThrGln * * Leu * * * * * * * * *
hp2FI.. ..G..T..T.T. A. A .. T.T AGAGAA.CCAG ..T... C.C. A. .G. .T. ..A.G. .T
* * * * * * * * * * * * * * * * * * * * * * * * LysArgThrGln * * * * * * * * * * * *
480
pHAT8 GGTGCGGCCGGCGCGACCTCCCTCTGCTTCGTGTACCCGCTGGATTTTGCCAGAACCCGCCTGGCAGCGGACGTGGGAAAGTCAGGCACAGAGCGCGAGTTCCGAGGCCTGGGAGACTGC
GlyAlaAlaGlyAlaThrSerLeuCysPheValTyrProLeuAspPheAlaArgThrArgLeuAlaAlaAspValGlyLysSerGlyThrGluArgGluPheArgGlyLeuGlyAspCys
pHAT3 . . .A..G..C..A...C. .T. .T. T..T. ..T T. .A. T. .T..... .AG.T ..AG.T..AA.C. ..C.C.T.
* * * * * * * * * * * * * * * * * * * * * * * * * * * Ala * Ala * * * * * * * * * *
hp2FI C..A..C..C. .A...G..T. .... . .T. C.T. .T.A. T. T. T. .AG.T ..AG.T ..AA.G..A... C. .T.
* * * * * * * * * * * * * * * * * * * * * * * * * * * Ala * Ala * * * * * * * * * *
600
pHAT8 CTGGTGAAGATCACCAAGTCCGACGGCATCCGGGGCCTGTACCAGGGCTTCAGTGTCTCCGTGCAGGGCATCATCATCTACCGGGCGGCCTACTTCGGCGTGTACGATACGGCCAAGGGC
LeuValLysIleThrLysSerAspGlylleArgG!yLeuTyrGlnGlyPheSerValSerValGlnGlyllellelleTyrArgAlaAlaTyrPheGiyValTyrAspThrAlaLysGly
pHAT3 .... GT. TA.. A. .T. .T. .TAA. A... T.AC. .G..T. T. .T.A. .C.TA.C. .T. .C. .T..A. A
* Gly * * Tyr * * * * * Lys * * * * * *Asn * * * * * * * * * * * * * * * Ile * * * * * *
hp2FI . T. TA.. . TA .T. .G. GTAA. A... T.AC. .G..T. T. .T.A... .C.TA.C. .T .C. .TA... A
* * * * Tyr * * * * * Lys * * * * * * Asn * * * * * * * * * * * * * * * Ile * * * * * *
720
pHAT8 ATGCTCCCCGACCCCAAGAACACGCACATCGTGGTGAGCTGGATGAICGCGCAGACCGTGACGGCCGTGGCCGGCGTGGTGTCCTACCCCTTCGACACGGTGCGGCGGCGCATGATGATG
MetLeuProAspProLysAsnThrHisIleValValSerTrpMetIleAlaGlnThrValThrAlaValAlaGlyValValSerTyrProPheAspThrValArgArgArgMetMetMet
pHAT3. . .G..T.. T. CA.C.A. . .C..T. .TT .T. GT. .ACT. T. ..A.. .. . .T..C..C.C.
* * * * * * * * * * * Ile * * * * * * * * * * * * * LeuThr * * * * * * * * * * * * *
hp2F T..G..T.. T. CA.C.A. . .C..T. .TT .T. GT. .ACT. T. ..A.. .. . .T..C..C.C.
* * * * * * * * * * * Ile * * * * * * * * * * * * * LeuThr * * * * * * * * * * * * *
840
pHAT8 CAGTCCGGGCGCAAAGGAGCTGACATCATGTACACGGGCACCGTCGACTGTTGGAGGAAGATCTTCAGAGATGAGGGGGGCAAGGCCTTCTTCAAGGGTGCGTGGTCCAACGTCCTGCGG
GlnSerGlyArgLysGlyAlaAspIleMetTyrThrGlyThrValAspCysTrpArgLysIePheArgAspGluGlyGlyLysAlaPhePheLysGlyAlaTrpSerAsnValLeuArg
pHAT3 ...A A... A. GC.T.C.. C..CTGCTC.T. A. A. A. .T.T. A. T. T. .CA.A
* * * * * * Thr * * * * * * * Leu * * * * * * Ala * * * * * * * * * * * * * * * * * *
hp2F1 ... A ..A..A. GC.T.C.. C. CTGCTC.T. A. A. A. .T .T.. A. T. T. .CA.A
* * * * * * Thr * * * * * * * Leu * * * * * * Ala * * * * * * * * * * * * * * * * * *
960
pHAT8 GGCATGGGGGGCGCCTTCGTGCTGGTCCTGTACGACGAGCTCAAGAAGGTGATC GGCCGCGGCCTCCTCCACACACACACACACACCAGGGGAACCAAGAGAACCACGTAGAATCC
GlyMetGly$lyAlaPheValLeuVal~euTyrAspGluLeuLysLyavalIle
pHAT3 T. T..T. .....T T . T..T. .AA. TAC.CA ... GTTATTTCCTAGGATTTTTCCCCCTGTGAACAGGCATGTTGTATTATATAACATA-TCTTGAG
* * * * * * * * * * * * * Ile * * TyrThr
hp2Fi . T. T..T. .....T T . T..T. .AA. TAC.CA ... GTTATTTCCTAGGATTTTTCCCCCTGTGAACAGGCATGTTGTATTCTATAACACAATCTTGAG
* * * * * * * * * * * * * Ile * * TyrThr
1080
pHAT8 TCAACCGTGCGGACCATCAACCTTCGAGAAATTCCAGTTGTCTTTTTCCCAGCCGCATCCTGCCTGTAGATGGCCGGGGAAGGCTCTAGAAAGGGGCGCATTGCGATCCAACCATCGGC
pHAT3 CATTCTTGACAGACTCCTGGCTGTCAGTTTCTCAGTGGCAACTA-TTTACTGGTTGAAAATGGGAAGCAATAATATTCATCTGACCAGTTTTCTCTTAAAGCCATTTCCATG-ATGATGA
hp2F1 CATTCTT'GACAGACTCCTGGCTGTCAGTTTCTCAGtGGCAACTACTTTACTGGTTGAAAATGGGAAGCAATAATATTCATCTGACCAGTTTTCTCTTAAAGCCATTTCCATGCATGATGA
1200
pHAT8 AGCCGATTCCGTGTCTTGATCACGGGGTGGGAGGGAACCGTGGCGTCCCTGCGTGGGGCCCATGGGTGAGACACTCCAGTACTGAGACCTAGAGTCCAGATGCTTGTAGGAGCCAAGTCG
pHAT3 TGATGGGACTCAATTGTATTTTTTATTTCAGTCACTCCTGA-TAAATAACAATTTGGAGAAT..AAATA-TCTAAAATAn
hp2FI TGATGGGACTCAATTGTATTTTTTATTTCAGTCACTCCTGACTAAATAACAATTTGGAGAAATAAAAATAGTCTAAAATAn
1223
pHAT8 TGTTCTAAGTATTTATTTAAAACAn
FIG. 2. Nucleotide and predicted amino acid sequence of the inserts of pHAT14, pHAT8, and pHAT3. The sequences of the inserts have
been aligned with the sequence of hp2F1 (6). A one-codon gap has been introduced in the reading frame ofpHAT8 at positions 322-324, to align
it with the reading frames ofpHAT3 and hp2F1. The initiation codon ofpHAT14 and the termination codon ofpHAT8 are boxed. In the reading
frames, nucleotides identical to those of pHAT14 and pHAT8 are indicated by dots; identical amino acids are indicated by asterisks. The
recognition site for polyadenylylation (21) in the 3' untranslated region of pHAT3 is doubly underlined. In the 3' untranslated region of hp2F1,
nucleotide substitutions or insertions as compared to the homologous region of pHAT3 are underlined.
corresponding codon changes: Arg and Val in hp2F1 to Leu amino acid gap at position 108 had to be introduced in the
and Gly, respectively, in pHAT3. The nucleotide difference sequence of pHAT8 to align it with the bovine sequence. In
at position 699 does not result in an amino acid substitution. the homologous maize (22), Neurospora (23), and yeast (24)
A number of nucleotide differences (seven substitutions or protein sequences, one amino acid gap is also observed in
deletions/insertions) were observed in the 3' untranslated this position. Interestingly, this gap is not present in hp2Fl
regions of hp2F1 and pHAT3 (Fig. 2). nor in pHAT3 (Fig. 2). The protein coding sequence of
Comparison of the Human and Bovine ADP/ATP Translo- pHAT14, 37 residues long, exhibits four differences from the
case Sequences. Fig. 3 shows the complete, directly deter- corresponding segment of the bovine protein (89% similar-
mined amino acid sequence of the ADP/ATP translocase ity). The 262 amino acid stretch encoded in pHAT8 differs
from bovine heart (25) and, underneath it, the deduced from the corresponding segment of the bovine protein at 26
sequences of pHAT14, pHAT8, hp2Fl, and pHAT3. One positions (90% similarity). A similar divergence from the
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FIG. 3. Comparison of the deduced amino acid sequences of the
inserts of the human ADP/ATP translocase cDNA clones pHAT14,
pHAT8, hp2F1, and pHAT3 with the amino acid sequence of the
bovine ADP/ATP translocase (25). The amino acid residues are
shown in standard single-letter symbols. Identical residues are
indicated by dots. Below the hp2F1 sequence, the residues that
differ in pHAT3 are shown in parentheses.
bovine sequence is exhibited by the protein encoded in the
human tran$locase cDNA clone hp2Fl (6) (90% similarity)
and by that encoded in pHAT3 (89% similarity). Between the
predicted sequences for the two human ADP/ATP translo-
case proteins identified here (encoded in pHAT8 and
pHAT3), there is 91% similarity in the common segment.
The amino acid differences on the whole tend to be in
clusters and do not occur in regions that are highly con-
served. The latter regions include the six hydrophobic
segments that are postulated to traverse the membrane as
a-helices and that are part of three repeated domains. The
whole polypeptide is thought to derive from an ancestral
gene by two duplication events (26).
Identification of ADP/ATP Translocase mRNAs in HeLa
Cells. Polyadenylylated RNA was isolated from HeLa
(human) cells and subjected to RNA transfer hybridization
analysis, using the inserts of the pHAT clones as probes. In
view of the evidence of the existence of multiple isoforms of
ADP/ATP translocase cDNAs, relatively low-stringency con-
ditions were used in the hybridizations. The results of these
experiments are shown in Fig. 4. When pHAT8 was used as
a probe, three RNA species reacting with the probe were
detected (Fig. 4a). The same three bands, with similar relative
intensities, were detected by hybridization with probes de-
rived from clones overlapping with pHAT8 (pHAT5, pH-
AT22, and pHAT32) (Fig. 4b). The most strongly hybridizing
band (b) corresponds to an RNA with a size of -1450 nt, as
estimated by comparison of its migration with that of the
mitochondrial RNA markers (Fig. 4b). Of the two other
bands, one corresponds to an RNA with a size of o1600 nt,
and the other represents an RNA species of -1300 nt.
When pHAT3 was used as a probe in 40%o formamide, it
hybridized exclusively to the c band (Fig. 4b). In 30%o formam-
ide, pHAT3 still hybridized predominantly to the c band, but
one could detect a weak hybridization to the b band and an
even weaker reaction with the a band (Fig. 4a). The pattern did
not change appreciably when the percentage offormamide was
a b
FA% 30 40 30 40
3 8 T1O M 3 5 22 32
c
20 30 40 40
14 14 14 8
4 .4G
5/-
I 122Ss,Z j ?
V 14,15-.
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FIG. 4. Hybridization analysis of HeLa cell mRNA. Polya-
denylylated RNA was isolated from HeLa cells, fractionated by
electrophoresis in a 1.1% agarose/5 mM CH3HgOH gel (3 ,utg per
lane), transferred to a nylon membrane, and then hybridized at 37°C
with 32P-labelecl cDNA probes. for ADP/ATP tramslocase. In a, 3 x
106 cpm of probe was used for the first lane (30-hr exposure), 6 x
106 cpm for the second lane, and 6 x 106 cpm for the third lane (17-hr
and 30-hr exposure, respectively); in b, 5 x 106 cpm per lane (7-hr
exposure) was used; and in c, 1.5 x 106 cpm per lane (22-hr exposure)
was used. Mitochondrial RNA species labeled in vitro (27) were used
as molecular weight markers (lane M). The sizes of 16S rRNA,
RNA11, 12S* rRNIA, and 12S rRNA are 1559, '1200, ~1045, and 954
nt (27, 28). The percent (vol/vol) formamnide (FA) present during
hybridization is indicated at the top; 3, 5, 8, 14, 22, 32 indicate cDNA
probes from pHAT3, pHAT5, pHAT8, pHAT14, pHIAT22, and
pHAT32, respectively, and T1O indicates a cDNA for bovine
ADP/ATP translocase. Bands a, b, and c are discussed intthe text.
lowered (to 20%o anld 10%) (not shown). It is also interesting
that the bovine cDNA probe TlO reacted predominantly with
the c band, and, in order of decreasing intensity, with the b and
a bands (Fig. 4a). The insert ofpHATl4 was found to hybridize
exclusively with band c, the reaction being in general weak and
decreasing with increasing formamide co~ncentration (Fig. 4c).
The fairly high background, possibly due to the poly(dG) tail,
prevented the detection of a possible minor hybridization with
the b and a species.
DISCUSSION
The cDNA library used in this work was constructed by
cutting out the cDNA inserts of another library (7) with Pst I
and inserting the fragments into Pst I-cleaved pEXi (8). As a
result, some of the original cDNA inserts were cut at internal
Pst I sites. The Pst I sites at the 5' end of pHAT3 and pHAT8
and at the 3' end of pHATl4 were generated in this way. The
human translocase cDNA clone hp2F1 recently identified (6)
has two Pst I sites, and it is from the second site that pHAT3
was found to extend towards the 3' end. In pHAT8, the Pst I
site at the same position has been lost due to mutation, while
the first site is retained, and it is from this site that pHAT8
extends towards the 3' end; pHAT14 extends also from this
site towards the 5' end (Fig. 1).
The main conclusion of this work is that two genes for the
ADP/ATP translocase are expressed at the mRNA level in
adult human liver. In fact, the protein-encoding sequences of
pHAT8 and pHAT3 are clearly distinct (23% divergence in
nucleotide sequence and 9% divergence in amino acid
sequence). Furthermore, the 3' untranslated regions of the
two inserts are totally different. The reading frame and 3'
untranslated region of pHAT3 are nearly identical to those of
the human cDNA hp2Fl, which is expressed in fibroblasts
(6). However, the differences are probably too many to be
explained by polymorphism. Although one cannot exclude
this possibility, the alternative explanation that the inserts of
pHAT3 and hp2Fl derive from two distinct genes seems
more likely.
pHATl4 is the most intriguing among the clones isolated
from the pEXl library. In principle, its insert could derive
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from the same liver mRNA from which the insert of pHAT8
or that of pHAT3 derives. The insert of pHAT8 was found to
react strongly with HeLa cell mRNA b, suggesting that this
may be the RNA from which that insert derives. If it is so,
the failure of pHAT14 to hybridize with mRNA b would
argue against the possibility that the inserts of pHAT8 and
pHAT14 have a common origin. On the other hand, if the
inserts of pHAT3 and hp2F1 derive from the same mRNA,
the insert of pHAT14 must have a different origin. In fact,
the reading frame of pHAT14 is clearly distinct from the
corresponding portion of the reading frame of hp2F1 (21%
divergence in nucleotide sequence and 14% in amino acid
sequence). Furthermore, its 5' untranslated region is totally
dissimilar from the 5' untranslated region of hp2F1. There-
fore, either the inserts of pHAT14 and pHAT3 share the
same origin, distinct from that of hp2F1, or the cDNA of
pHAT14 derives from an mRNA different from that (those)
generating the pHAT3 and hp2F1 cDNAs. The observation
that pHAT14 hybridizes with the HeLa cell mRNA c with
which pHAT3 exhibits a strong reaction would support the
idea that the two clones derive from the same cDNA.
However, pHAT14 hybridizes with mRNA c much less
strongly than expected for the size of its insert, and its
reaction with this RNA decreases with increasing formamide
concentration, despite its high G + C content (68%). These
two facts argue more in favor of the interpretation that the
insert of pHAT14 originates from a liver mRNA distinct
from that from which pHAT3 derives. In fact, this mRNA
may not be present at all in HeLa cells, the reaction of
pHAT14 with HeLa cell mRNA c being due to cross-
hybridization. This interpretation would imply that three
different genes for the ADP/ATP translocase (corresponding
to the cDNAs of pHAT14, pHAT8, and pHAT3) are ex-
pressed in adult human liver. Further work is needed to
clarify this issue. Whatever the relationship of pHAT14 to
pHAT3 is, the available evidence suggests that at least three
different genes for the ADP/ATP translocase ate expressed
in different human tissues.
The analysis of the translocase-specific mRNAs in HeLa
cells has revealed three discrete mRNA species, with sizes
of 1300, 1450, and 1600 nt. The different relative intensities
of the signals produced by hybridization of these mRNA
species with pHAT3, pHAT8, and pHAT14 presumably
reflect in part different degrees of sequence similarities and
in part differences in G + C content of the three inserts. In
fact, the insert of pHAT3 has a G + C content of 46.5%, that
of pHAT8, 60.5%, and that of pHAT14, 68%.
The shortest mRNA (species c), which showed in the
present work the strongest hybridization with pHAT3, is
smaller than the mRNA from a human promyelocytic leuke-
mia cell line, which was previously reported to be the only
mRNA hybridizing with hp2F1 (6). The latter species was
estimated to be '1500 nt in length and was assumed to
correspond to the 1228 bp of the complete or near-complete
cDNA isolated from human fibroblasts plus a poly(A) tail. If
the missing segment of the cDNA ofpHAT3 is similar in size
to the equivalent region of the insert of hp2F1 (205 bp,
including a 69-nt 5' untranslated segment and a 136-nt coding
stretch), and if the mRNA corresponding to pHAT3 is
indeed the species c detected in HeLa cells, this mRNA
would have a poly(A) tail of an unusually short size (s70
residues). On the other hand, it is possible that the mRNA
species c expressed in HeLa cells has a shorter 5' or 3'
untranslated region compared to hp2Fl. This would imply a
complexity of the genes for the ADP/ATP translocase even
greater than so far suspected. In previous work (29), two
distinct mRNAs with sizes of 1200 and 1500 nt were detected
in bovine tissues (heart, kidney, liver, and uterus) by using
ADP/ATP translocase cDNA clones isolated from a bovine
heart library as probes. It was postulated that these two
mRNAs differ in the lengths of their 5' untranslated region.
A remarkable feature of these mRNAs is their very short 3'
untranslated region (26 or 27 nt).
The 1600-nt mRNA species (a), which hybridizes to a
moderate extent with pHAT8 and very weakly with pHAT3
and with the bovine ADP/ATP translocase clone T10, very
probably also codes for an ADP/ATP translocase. The rela-
tively weak hybridization of this RNA species with the
ADP/ATP translocase-specific clones, as compared to mRNA
species b and c, could reflect a lower amount ofan RNA similar
in sequence to that from which the cDNA ofpHAT8 or pHAT3
derives, or the presence of an RNA with a more divergent
sequence of the protein coding region. Its larger size may be
due to a longer 5' and/or 3' untranslated region, as compared to
pHAT8, pHAT3, and hp2F1. In any case, the presence of this
mRNA in HeLa cells points to the possible existence of
another gene for the ADP/ATP translocase or to a different
transcription or RNA processing pathway.
It is clear from the results reported here that two, and very
probably more, genes for the ADP/ATP translocase exist
and are expressed in the human genome. This work thus
provides a basis, at the gene structure level, for the previous
immunological evidence of tissue specificity of the ADP/
ATP translocase (2-5). Further work on the organization of
the ADP/ATP translocase genes and on the pattern of their
expression should reveal the significance of the complexity
of the genetic control of this key protein in relationship to
functional, developmental, and tissue-specific factors.
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